Company intelligence / Profile preview
FibroX Therapeutics
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
FibroX Therapeutics is a Shanghai-based biotechnology company specializing in the development of innovative cell therapies for degenerative musculoskeletal diseases. The company's proprietary platform leverages allogeneic human dermal fibroblasts to promote tissue repair, reduce inflammation, and restore structural stability. Its lead candidate, FibroCell-001 (an allogeneic human fibroblast injection), is currently in Phase 1/2 clinical development for the treatment of moderate-to-severe lumbar disc degenerative disease. FibroX Therapeutics is also expanding its pipeline to target other high-unmet-need indications, including rotator cuff injuries, ligament damage, and senile refractory fractures.
- Therapeutic areas
- OtherRheumatologyEndocrinology
- Modalities
- Cell therapyBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Shanghai Ninth People's HospitalShanghai Jiao Tong University School of Medicine
Beyond the preview
Go deeper on FibroX Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FibroX Therapeutics.